Rapid Nutrition Announces Analyst Coverage Update by Argus
December 20, 2019
LONDON UK, - Rapid Nutrition PLC (RAP:SW, OTCQB: RPNRF)("Company"), a natural healthcare company focused on the research, development and production of a range of life science products, today announced that Argus Research Co. ("Argus") has published their update Equity Report coverage on the Company.
Rapid Nutrition CEO, Simon St. Ledger, stated, "We are pleased to provide current and prospective investors with this Argus Equity Report written by a seasoned Argus equity analyst, affording additional insights as to our strategic growth opportunities. Furthermore, we believe this research will effectively supplement our efforts to engage with the capital markets."
Argus Research Co., founded in 1934, is a leading provider of independent research and analysis on U.S. equities to the professional market. Rapid Nutrition has engaged Argus through its company-sponsored research service.
Argus Equity Report Update on Rapid Nutrition can be viewed via the following link: Rapid Nutrition PLC Argus Research Report
Investor Relations Contact:
About Rapid Nutrition
Rapid Nutrition is a natural healthcare company focused on the research, development and production of a range of life science products. The company was established based on its successful and proven weight loss supplement range which is exported worldwide and now offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns, as well as a providing number of wider services to the life sciences industry. For more information, please visit http://rnplc.com
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause Rapid Nutrition’s actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. You should not place undue reliance on any forward-looking statements. Rapid Nutrition undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b)